Thus, AEBP1 has been shown not only to mediate that expression of EMT-related components through NF-κB signaling, but also to promote the progression and metastatic features of COAD, in vitro and in vivo, via the canonical NF-κB pathway. The gene discussed is AEBP1; the disease is colon adenocarcinoma.